BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34448021)

  • 1. Early white matter pathology in the fornix of the limbic system in Huntington disease.
    Gabery S; Kwa JE; Cheong RY; Baldo B; Ferrari Bardile C; Tan B; McLean C; Georgiou-Karistianis N; Poudel GR; Halliday G; Pouladi MA; Petersén Å
    Acta Neuropathol; 2021 Nov; 142(5):791-806. PubMed ID: 34448021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early white matter abnormalities, progressive brain pathology and motor deficits in a novel knock-in mouse model of Huntington's disease.
    Jin J; Peng Q; Hou Z; Jiang M; Wang X; Langseth AJ; Tao M; Barker PB; Mori S; Bergles DE; Ross CA; Detloff PJ; Zhang J; Duan W
    Hum Mol Genet; 2015 May; 24(9):2508-27. PubMed ID: 25609071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into White Matter Defect in Huntington's Disease.
    Sun Y; Tong H; Yang T; Liu L; Li XJ; Li S
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrinsic mutant HTT-mediated defects in oligodendroglia cause myelination deficits and behavioral abnormalities in Huntington disease.
    Ferrari Bardile C; Garcia-Miralles M; Caron NS; Rayan NA; Langley SR; Harmston N; Rondelli AM; Teo RTY; Waltl S; Anderson LM; Bae HG; Jung S; Williams A; Prabhakar S; Petretto E; Hayden MR; Pouladi MA
    Proc Natl Acad Sci U S A; 2019 May; 116(19):9622-9627. PubMed ID: 31015293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linking white matter and deep gray matter alterations in premanifest Huntington disease.
    Faria AV; Ratnanather JT; Tward DJ; Lee DS; van den Noort F; Wu D; Brown T; Johnson H; Paulsen JS; Ross CA; Younes L; Miller MI;
    Neuroimage Clin; 2016; 11():450-460. PubMed ID: 27104139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelin Breakdown in Human Huntington's Disease: Multi-Modal Evidence from Diffusion MRI and Quantitative Magnetization Transfer.
    Bourbon-Teles J; Bells S; Jones DK; Coulthard E; Rosser A; Metzler-Baddeley C
    Neuroscience; 2019 Apr; 403():79-92. PubMed ID: 28579146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligodendrocyte pathology in Huntington's disease: from mechanisms to therapeutics.
    Ferrari Bardile C; Radulescu CI; Pouladi MA
    Trends Mol Med; 2023 Oct; 29(10):802-816. PubMed ID: 37591764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothalamic and Limbic System Changes in Huntington's Disease.
    Petersén A; Gabery S
    J Huntingtons Dis; 2012; 1(1):5-16. PubMed ID: 25063186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quantitative MR measure of the fornix in schizophrenia.
    Zahajszky J; Dickey CC; McCarley RW; Fischer IA; Nestor P; Kikinis R; Shenton ME
    Schizophr Res; 2001 Jan; 47(1):87-97. PubMed ID: 11163548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications.
    Bartzokis G; Lu PH; Tishler TA; Fong SM; Oluwadara B; Finn JP; Huang D; Bordelon Y; Mintz J; Perlman S
    Neurochem Res; 2007 Oct; 32(10):1655-64. PubMed ID: 17484051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive Control, Learning, and Clinical Motor Ratings Are Most Highly Associated with Basal Ganglia Brain Volumes in the Premanifest Huntington's Disease Phenotype.
    Misiura MB; Lourens S; Calhoun VD; Long J; Bockholt J; Johnson H; Zhang Y; Paulsen JS; Turner JA; Liu J; Kara B; Fall E;
    J Int Neuropsychol Soc; 2017 Feb; 23(2):159-170. PubMed ID: 28205498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural variation in sensory-motor white matter organization influences manifestations of Huntington's disease.
    Orth M; Gregory S; Scahill RI; Mayer IS; Minkova L; Klöppel S; Seunarine KK; Boyd L; Borowsky B; Reilmann R; Bernhard Landwehrmeyer G; Leavitt BR; Roos RA; Durr A; Rees G; Rothwell JC; Langbehn D; Tabrizi SJ;
    Hum Brain Mapp; 2016 Dec; 37(12):4615-4628. PubMed ID: 27477323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural biological variation of white matter microstructure is accentuated in Huntington's disease.
    Gregory S; Crawford H; Seunarine K; Leavitt B; Durr A; Roos RAC; Scahill RI; Tabrizi SJ; Rees G; Langbehn D; Orth M
    Hum Brain Mapp; 2018 Sep; 39(9):3516-3527. PubMed ID: 29682858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal change in white matter microstructure in Huntington's disease: The IMAGE-HD study.
    Poudel GR; Stout JC; Domínguez D JF; Churchyard A; Chua P; Egan GF; Georgiou-Karistianis N
    Neurobiol Dis; 2015 Feb; 74():406-12. PubMed ID: 25497085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant Hippocampal Functional Connectivity Is Associated with Fornix White Matter Integrity in Alzheimer's Disease and Mild Cognitive Impairment.
    Wang P; Zhou B; Yao H; Xie S; Feng F; Zhang Z; Guo Y; An N; Zhou Y; Zhang X; Liu Y
    J Alzheimers Dis; 2020; 75(4):1153-1168. PubMed ID: 32390630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease.
    Fennema-Notestine C; Archibald SL; Jacobson MW; Corey-Bloom J; Paulsen JS; Peavy GM; Gamst AC; Hamilton JM; Salmon DP; Jernigan TL
    Neurology; 2004 Sep; 63(6):989-95. PubMed ID: 15452288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal ganglia-cortical structural connectivity in Huntington's disease.
    Novak MJ; Seunarine KK; Gibbard CR; McColgan P; Draganski B; Friston K; Clark CA; Tabrizi SJ
    Hum Brain Mapp; 2015 May; 36(5):1728-40. PubMed ID: 25640796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain structure in juvenile-onset Huntington disease.
    Tereshchenko A; Magnotta V; Epping E; Mathews K; Espe-Pfeifer P; Martin E; Dawson J; Duan W; Nopoulos P
    Neurology; 2019 Apr; 92(17):e1939-e1947. PubMed ID: 30971481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo characterization of white matter pathology in premanifest huntington's disease.
    Zhang J; Gregory S; Scahill RI; Durr A; Thomas DL; Lehericy S; Rees G; Tabrizi SJ; Zhang H;
    Ann Neurol; 2018 Oct; 84(4):497-504. PubMed ID: 30063250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic load determines atrophy in hand cortico-striatal pathways in presymptomatic Huntington's disease.
    Hong Y; O'Donnell LJ; Savadjiev P; Zhang F; Wassermann D; Pasternak O; Johnson H; Paulsen J; Vonsattel JP; Makris N; Westin CF; Rathi Y
    Hum Brain Mapp; 2018 Oct; 39(10):3871-3883. PubMed ID: 29797744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.